Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,505 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $210.12 | 3 | $0 (2024) |
| Novo Nordisk Inc | $148.39 | 2 | $0 (2024) |
| Eisai Inc. | $125.00 | 1 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $125.00 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $125.00 | 1 | $0 (2024) |
| SCYNEXIS, Inc. | $112.91 | 1 | $0 (2022) |
| Lilly USA, LLC | $100.00 | 1 | $0 (2024) |
| Sage Therapeutics, Inc. | $97.56 | 1 | $0 (2023) |
| Mylan Specialty L.P. | $90.46 | 1 | $0 (2022) |
| Inspire Medical Systems, Inc. | $84.95 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $988.66 | 11 | Novo Nordisk Inc ($148.39) |
| 2023 | $312.51 | 4 | Sage Therapeutics, Inc. ($97.56) |
| 2022 | $203.37 | 2 | SCYNEXIS, Inc. ($112.91) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: COVID-19 | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $89.42 | General |
| Category: Obesity | ||||||
| 09/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $58.80 | General |
| Category: EPILEPSY | ||||||
| 09/13/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Neuropsychiatry | ||||||
| 09/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: PSYCHIATRY | ||||||
| 07/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $58.97 | General |
| Category: Obesity | ||||||
| 06/06/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $84.95 | General |
| Category: NEUROLOGY | ||||||
| 04/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $100.00 | General |
| Category: Diabetes | ||||||
| 01/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $96.52 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $63.60 | General |
| Category: NEUROLOGY | ||||||
| 08/24/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $69.23 | General |
| 03/09/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $82.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/16/2023 | Sage Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $97.56 | General |
| 11/10/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $90.46 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/17/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $112.91 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 250 | 800 | $84,860 | $48,230 |
| 2021 | 5 | 388 | 1,198 | $126,448 | $77,725 |
| 2020 | 4 | 113 | 295 | $21,687 | $10,720 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 159 | 696 | $69,600 | $39,301 | 56.5% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 75 | 87 | $13,050 | $7,790 | 59.7% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 16 | 17 | $2,210 | $1,138 | 51.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 231 | 1,028 | $102,880 | $64,174 | 62.4% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 79 | 82 | $12,300 | $7,435 | 60.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2021 | 24 | 24 | $4,320 | $3,487 | 80.7% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2021 | 34 | 34 | $4,420 | $2,446 | 55.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 20 | 30 | $2,528 | $183.42 | 7.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 33 | 205 | $17,523 | $8,080 | 46.1% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Office | 2020 | 22 | 22 | $2,612 | $1,405 | 53.8% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 29 | 34 | $791.08 | $654.56 | 82.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 29 | 34 | $760.40 | $581.40 | 76.5% |
About Doreen Karan
Doreen Karan is a Adult Health healthcare provider based in Bala Cynwyd, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2015. The National Provider Identifier (NPI) number assigned to this provider is 1598120693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Doreen Karan has received a total of $1,505 in payments from pharmaceutical and medical device companies, with $988.66 received in 2024. These payments were reported across 17 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,505).
As a Medicare-enrolled provider, Karan has provided services to 751 Medicare beneficiaries, totaling 2,293 services with total Medicare billing of $136,675. Data is available for 3 years (2020–2022), covering 12 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Bala Cynwyd, PA
- Active Since 12/16/2015
- Last Updated 12/16/2015
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1598120693
Products in Payments
- Wegovy (Drug) $148.39
- REXULTI (Drug) $146.52
- Leqembi (Drug) $125.00
- Veklury (Drug) $125.00
- Velphoro (Drug) $125.00
- MOUNJARO (Drug) $100.00
- Yupelri (Drug) $90.46
- INSPIRE (Device) $84.95
- LOKELMA (Drug) $82.12
- INGREZZA (Drug) $75.00
- NUEDEXTA (Drug) $63.60
- VALTOCO (Drug) $58.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.